Article
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Bearish
-55.0
−100 Bearish
0
+100 Bullish
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This